Phase 3 Bladder Carcinoma Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Stage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8Recurrent Non-Muscle Invasive Bladder Carcinoma
Alliance for Clinical Trials in Oncology330 enrolled56 locationsNCT07000084
Recruiting
Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Bladder Carcinoma in Situ (CIS)
Fidia Farmaceutici s.p.a.112 enrolled47 locationsNCT05024773
Recruiting
Phase 2Phase 3
NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment
Muscle-Invasive Bladder Carcinoma
Peter Black688 enrolled1 locationNCT06537154
Recruiting
Phase 3
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
Bladder CarcinomaBladder NeoplasmMuscle Invasive Bladder Cancer (MIBC)+2 more
University of Rome Tor Vergata92 enrolled1 locationNCT07067749
Recruiting
Phase 3
Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Gall Bladder Carcinoma
Rajiv Gandhi Cancer Institute & Research Center, India114 enrolled3 locationsNCT06712420
Recruiting
Phase 2Phase 3
Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
Metastatic Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma
Vasgene Therapeutics, Inc700 enrolled1 locationNCT06493552
Completed
Phase 3
Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)
muscle invasive gallbladder carcinoma
Australasian Gastro-Intestinal Trials Group40 enrolled16 locationsACTRN12615001283561